Human metapneumovirus viral load is an important risk factor for disease severity in young children

Journal of Clinical Virology

Volumn 60, Issue 2, 2014, Pages 133-140

  Roussy, Jean François ^a   Carbonneau, Julie ^a   Ouakki, Manale ^b   Papenburg, Jesse ^c   Hamelin, Marie Ève ^a   De Serres, Gaston ^b   Boivin, Guy ^a  

^a LAVAL UNIVERSITY   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Hospitalization; Human metapneumovirus; Pediatric; Severity; Viral load

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

ARTICLE; BRONCHIOLITIS; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CRACKLE; DISEASE SEVERITY; DRUG USE; FEMALE; GENOTYPE; HOSPITALIZATION; HOUSEHOLD; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; INFANT; LOW BIRTH WEIGHT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NASOPHARYNGEAL ASPIRATION; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; VIRUS DETECTION; VIRUS LOAD; ISOLATION AND PURIFICATION; METAPNEUMOVIRUS; NASOPHARYNX; NEWBORN; PARAMYXOVIRUS INFECTION; PATHOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; VIROLOGY;

CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; METAPNEUMOVIRUS; NASOPHARYNX; PARAMYXOVIRIDAE INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 84900300940     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.03.001     Document Type: Article

References (32)

1. Monto A.S. Epidemiology of viral respiratory infections. Am J Med 2002, 112:4-12.
2. Kahn J.S. Epidemiology of human metapneumovirus. Clin Microbiol Rev 2006, 19:546-557.
3. van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001, 7:719-724.
4. Feuillet F., Lina B., Rosa-Calatrava M., Boivin G. Ten years of human metapneumovirus research. J Clin Virol 2012, 53:97-105.
5. Papenburg J., Carbonneau J., Isabel S., Bergeron M.G., Williams J.V., De Serres G., et al. Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decade. J Clin Virol 2013, 58:541-547.
6. Schildgen V., van den Hoogen B., Fouchier R., Tripp R.A., Alvarez R., Manoha C., et al. Human metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev 2011, 24:734-754.
7. Agapov E., Sumino K.C., Gaudreault-Keener M., Storch G.A., Holtzman M.J. Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness. J Infect Dis 2006, 193:396-403.
8. Xiao N.G., Xie Z.P., Zhang B., Yuan X.H., Song J.R., Gao H.C., et al. Prevalence and clinical and molecular characterization of human metapneumovirus in children with acute respiratory infection in China. Pediatr Infect Dis J 2010, 29:131-134.
9. Vicente D., Montes M., Cilla G., Perez-Yarza E.G., Perez-Trallero E. Differences in clinical severity between genotype A and genotype B human metapneumovirus infection in children. Clin Infect Dis 2006, 42:e111-e113.
10. Pitoiset C., Darniot M., Huet F., Aho S.-L., Pothier P., Manoha C. Human metapneumovirus genotypes and severity of disease in young children (n=100) during a 7-year study in Dijon hospital, France. J Med Virol 2010, 82:1782-1789.
11. Papenburg J., Hamelin M.-È., Ouhoummane N., Carbonneau J., Ouakki M., Raymond F., et al. Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J Infect Dis 2012, 206:178-189.
12. Bosis S., Esposito S., Osterhaus A.D.M.E., Tremolati E., Begliatti E., Tagliabue C., et al. Association between high nasopharyngeal viral load and disease severity in children with human metapneumovirus infection. J Clin Virol 2008, 42:286-290.
13. Martin E.T., Kuypers J., Heugel J., Englund J.A. Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus. Diagn Microbiol Infect Dis 2008, 62:382-388.
14. Gern J.E., Martin M.S., Anklam K.A., Shen K., Roberg K.A., Carlson-Dakes K.T., et al. Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol 2002, 13:386-393.
15. Lemanske R.F., Jackson D.J., Gangnon R.E., Evans M.D., Li Z., Shult P.A., et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005, 116:571-577.
16. Kriegova E., Arakelyan A., Fillerova R., Zatloukal J., Mrazek F., Navratilova Z., et al. PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells. BMC Mol Biol 2008, 9:69.
17. Klemenc J., Asad Ali S., Johnson M., Tollefson S.J., Talbot H.K., Hartert T.V., et al. Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirus. J Clin Virol 2012, 54:371-375.
18. Edwards K.M., Zhu Y., Griffin M.R., Weinberg G.A., Hall C.B., Szilagyi P.G., et al. Burden of human metapneumovirus infection in young children. N Engl J Med 2013, 368:633-643.
19. DeVincenzo J.P. Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesis. Pediatr Infect Dis J 2005, 24:S177-S183. [discussion S82].
20. Sloots T.P., Mackay I.M., Bialasiewicz S., Jacob K.C., McQueen E., Harnett G.B., et al. Human metapneumovirus, Australia, 2001-2004. Emerg Infect Dis 2006, 12:1263-1266.
21. Ricart S., Garcia-Garcia J.J., Anton A., Pumarola T., Pons M., Muñoz-Almagro C., et al. Analysis of human metapneumovirus and human bocavirus viral load. Pediatr Infect Dis J 2013, 32:1032-1034.
22. Nokso-Koivisto J., Pyles R.B., Miller A.L., Patel J.A., Loeffelholz M., Chonmaitree T. Viral load and acute otitis media development after human metapneumovirus upper respiratory tract infection. Pediatr Infect Dis J 2012, 31:763-766.
23. Gerna G., Sarasini A., Percivalle E., Campanini G., Rovida F., Marchi A., et al. Prospective study of human metapneumovirus infection: diagnosis, typing and virus quantification in nasopharyngeal secretions from pediatric patients. J Clin Virol 2007, 40:236-240.
24. Williams J.V., Edwards K.M., Weinberg G.A., Griffin M.R., Hall C.B., Zhu Y., et al. Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis 2010, 201:1890-1898.
25. Jones M., Castile R., Davis S., Kisling J., Filbrun D., Flucke R., et al. Forced expiratory flows and volumes in infants. Am J Respir Crit Care Med 2000, 161:353-359.
26. Manoha C., Espinosa S., Aho S.-L., Huet F., Pothier P. Epidemiological and clinical features of hMPV, RSV and RVs infections in young children. J Clin Virol 2007, 38:221-226.
27. Ali S.A., Williams J.V., Chen Q., Faori S., Shehabi A., Jundi E.A., et al. Human metapneumovirus in hospitalized children in Amman, Jordan. J Med Virol 2010, 82:1012-1016.
28. Wang Y., Chen Z., Yan Y., Guo H., Chu C., Liu J., et al. Seasonal distribution and epidemiological characteristics of human metapneumovirus infections in pediatric inpatients in Southeast China. Arch Virol 2013, 158:417-424.
29. Spaeder M.C., Custer J.W., Bembea M.M., Aganga D.O., Song X., Scafidi S. A multicenter outcomes analysis of children with severe viral respiratory infection due to human metapneumovirus. Pediatr Crit Care Med 2013, 14:268-272.
30. Samson L. Prevention of respiratory syncytial virus infection. Paediatr Child Health 2009, 14:521-526.
31. Alvarez R., Elbashir S., Borland T., Toudjarska I., Hadwiger P., John M., et al. RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother 2009, 53:3952-3962.
32. El Saleeby C.M., Bush A.J., Harrison L.M., Aitken J.A., DeVincenzo J.P. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis 2011, 204:996-1002.